|Beike provides stem cells from three sources: umbilical cord blood, mesenchymal umbilical cord, and autologous bone marrow. After reviewing the patients full medical information, our medical department doctors will recommend which source of stem cells should be used for treatment. In some cases, the protocols for some patients may include the use of more than one type of stem cells.
Umbilical Cord Blood (UCB) Stem Cells
For many ailments such as spinal muscular atrophy, ataxia, and optic nerve conditions, Beike’s protocols utilize using UCB stem cells. Our UCB stem cell injections consist of three subsets of stem cells. These are hematopoietic stem cells, endothelial progenitor cells, and mesenchymal stem cells. As has been shown in numerous studies, hematopoietic stem cells and endothelial progenitor stem cells are likely to form tissues in the body. Mesenchymal stem cells can assist in the growth of chondrocytes (a type of cell critical to tissue renewal, particularly cartilage), liver cells, kidney cells, and neurons. They also conduct repairs in relation to vascular disorders within the brain, ocular areas, and throughout the body including the heart, kidney, and pancreas. However, generally at this stage of stem cell research, it is believed that the benefits patients state they have come from the cell growth factors that are released by the stem cells after administration.
Based upon recent research publications and experience, Beike’s protocols utilize UC-MSC stem cells for appropriate conditions. These injections contain a higher percentage of mesenchymal stem cells than the UCB injections and closely resemble the makeup of the injections cultured from patients’ own bone marrow. All MS and SCI patients receive this type of stem cell injection as the cells not only produce important growth factors and differentiate into desired cell types but can also regulate the immune system, reducing inflammation, scarring, and cell apoptosis (death).
For some disorders including Spinal Cord Injuries, Cerebral Palsy, Traumatic Brain Injury, Diabetic Foot, Femur Head Necrosis, and Heart Diseases, doctors may offer the option of using of the patients own bone marrow stem cells (depending on the patients individual condition). Stem cells can be cultured from the withdrawn bone marrow and these cells, depending on the quality of bone marrow and can create one or two separate injections. These injections also have a high concentration of mesenchymal stem cells. BM stem cells can be a viable option for those who would only like to utilize their own stem cells.
|الخلايا الجذعيه الناضجه
ولعلاج بَعْض الاِضطراباتِ بما في ذلك إصابات الحبل الشوكي، الشلل الدماغي، والرضوض الدماغِية، قدم السُكّري، نخر رأس عظمِ الفخذ، وأمراض القلب، قَدْ يَعْرض الأطباء خيارَ استعمال الخلايا الجذعية لنُخاعِ عظم المريضَ نفسه (اعتمادا على الحالة الخاصة لكل مريضَ). الخلايا الجذعية يُمْكِنُ أَنْ تأخذ مِنْ نُخاعِ العظم المستخلص ومن تلك الخلايا (اعتمادا على جودة نُخاعِ العظم) يُمْكِنُ أَنْ يصنع منها حقنه او حقنتان منفصلتان. هذه الحُقَنِ لَها أيضاً تركيز عالي من الخلايا البرانيشيمية الجذعية ويُمكنُ لخلايا نُخاعَ العظم الجذعية أَنْ تتوافر بالعديد من الخيارات الفعّالة لأولئك الذين يَحْبّذون أَنْ يَستعملوا خلاياهم الجذعية الخاصة فقط َ